Stasinos Chr. Sikalias · The science of compounding

Nonionic lotion base I — FNFB

CGR-BR-007 · ANVISA — Formulário Nacional da Farmacopeia Brasileira, 2ª edição, Revisão 02 (2012)

Historical source editionCGR-BR-007Brazil

HISTORICAL SOURCE EDITION — compare with the current edition before use.

Web edition 4.0 correction: Correction of internal base cross-references. Use the following register IDs instead of the IDs in the original PDF Dependencies field:
Paraben concentrate 6% + 3% w/w → CGR-BR-001
Imidazolidinyl urea 50% w/v preservative solution → CGR-BR-003

Dosage formSemi-solid base
Reference batch100 g
Monograph version4.0
Source packagev4

Source formula

IngredientSource quantity
Disodium edetate (A)0.1 g
FNFB paraben concentrate (A)3.3 g
Methyl gluceth-20 (A)5 g
Almond oil (B)3 g
Nonionic self-emulsifying wax, source composition (B)9 g
Butylated hydroxytoluene (B)0.05 g
Cyclomethicone and dimethiconol (B)2 g
Ceteareth-20 (B)0.5 g
Cyclomethicone (C)2.5 g
Imidazolidinyl urea 50% w/v solution (C)0.6 g
Purified water (A)q.s. ad 100 g
FNFB pH adjuster, if requiredq.s. pH 5.5–6.5

Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.

Description

Partial evidence

Semi-solid base: Nonionic lotion base I — FNFB. Additional appearance criteria are not established by the specific text reviewed.

References: [1]

Use and action

Documented in source

Nonionic emollient O/W base.

References: [1]

Specifications

Documented in source

pH 5.5–6.5.

References: [1]

Light

Partial evidence

Protect almond oil from light.
For the finished product the source specifies:
Well-closed opaque plastic container, protected from light, room temperature.

References: [1] · [2]

Air

Partial evidence

Almond oil: protect from air to limit rancidity.

References: [2]

Water and solubility

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Humidity

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Temperature

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

pH and related incompatibilities

Partial evidence

Specification of this preparation, not a demonstrated stability range:
pH 5.5–6.5.

References: [1]

Other incompatibilities

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Ingredient-specific information

Partial evidence

Almond oil (B): Almond oil: protect from air to limit rancidity.
These are selected facts for identified ingredients; relevant sensitivities and incompatibilities are detailed in the corresponding fields. This is not a complete SDS for every material.

References: [2]

Personal protective equipment

Partial evidence

Complete formula-specific PPE is not specified. Select gloves, eye protection and exposure controls using the exact materials’ SDS and the local risk assessment.
Supplementary AEMPS framework: clean long-sleeved laboratory clothing, hair covering and dedicated footwear/overshoes. Powder handling requires suitable eye/respiratory protection; change gloves with activity or damage. Select the exact type/material using SDS and risk assessment.

References: [1] · [3]

Risks and precautions

Partial evidence

A complete formula-specific hazard classification is not established. Assess potency, dust/aerosol, allergens, solvents, microbial risk and cross-contamination using the actual materials and process. Absence of a flag does not establish absence of hazard.

References: [1]

Compounding conditions

Partial evidence

Follow the addition sequence, temperatures and times stated under Preparation Procedure. The specific monograph is not a complete qualification of the local facility/equipment.

References: [1]

BUD rationale

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
The source period applies to its exact composition, method and packaging. It is not this batch’s expiry date and cannot be transferred to another vehicle/strength. Calculate the actual date in the blank batch record.

References: [1]

Bases and dependencies

Editorial correction

Paraben concentrate 6% + 3% w/w → CGR-BR-001
Imidazolidinyl urea 50% w/v preservative solution → CGR-BR-003

Equipment

Editorial checklist

Indicative checklist derived from the method: Balance of suitable resolution, Containers and mixing tools compatible with the materials, Controlled heating and thermometer, Calibrated pH meter. Selection/qualification is defined locally.

References: [1]

Preparation procedure

Documented in source

Heat A and B separately to about 70–75 °C. Add A to B with gentle stirring. Cool with stirring to about 40 °C, add C and check/adjust pH.

References: [1]

Observations

Documented in source

Source wax comprises cetearyl alcohol, ceteareth-20, mineral oil, lanolin alcohol and petrolatum. Qualify this composite grade and silicone blend before adoption.

References: [1]

Packaging

Documented in source

Well-closed opaque plastic container, protected from light, room temperature.

References: [1]

Quality control

Partial evidence

pH 5.5–6.5.

References: [1]

Storage

Documented in source

Well-closed opaque plastic container, protected from light, room temperature.

References: [1]

Dispensing and directions

Partial evidence

No additional special directions are established beyond the source route, storage and notes. Complete patient details, dose and directions from the prescription.

References: [1]

Labelling

editorial_specimen

Nonionic lotion base I — FNFB
Strength/variant: __________ Quantity: __________
Batch: __________ Prepared: __________ Use by: __________
Για εργαστηριακή ενσωμάτωση / For incorporation during compounding
Dose/directions: __________
Storage: Well-closed opaque plastic container, protected from light, room temperature.

References: [1]

Sources and traceability

  1. ANVISA — Formulário Nacional da Farmacopeia Brasileira, 2ª edição, Revisão 02 (2012)

    2012, 2nd ed., Rev. 02 — superseded · PDF pp. 185 · A2

    Review date reported in supplied metadata: 2026-09-10

  2. FN/2003/PA/003 ALMENDRAS, ACEITE VIRGEN DE

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–2 · A1

    Review date reported in supplied metadata: 2026-09-10

  3. PN/L/PG/002/00 INDUMENTARIA

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–5 · A1

    Review date reported in supplied metadata: 2026-09-10

Provenance and reuse

This record comes from the supplied v4 collection. Primary-source rights and licences remain separate. No new comprehensive licence review has been performed for the earlier 239 records.

SHA-256 of the supplied PDF: ca5bd7418e3ec96cef43e794771909ec4ee90e03535b481b5bbad87b1c143289